Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-15 6:07 pm Purchase | 2025-12-11 | 13D | Kymera Therapeutics, Inc. KYMR | BIOTECHNOLOGY VALUE FUND L P | 6,867,809 8.500% | 1,036,638 (+17.78%) | Filing History |
| 2025-11-24 5:05 pm Unchanged | 2025-11-20 | 13D | Repare Therapeutics Inc. RPTX | BIOTECHNOLOGY VALUE FUND L P | 10,333,600 24.000% | 0 (Unchanged) | Filing History |
| 2025-11-19 5:10 pm Purchase | 2025-11-17 | 13D | Inventiva S.A. IVA | BIOTECHNOLOGY VALUE FUND L P | 9,569,863 4.990% | 1,024,364 (+11.99%) | Filing History |
| 2025-11-14 4:26 pm Sale | 2025-09-30 | 13G | Zymeworks Inc. ZYME | BIOTECHNOLOGY VALUE FUND L P | 3,938,641 5.200% | -669,294 (-14.52%) | Filing History |
| 2025-11-14 4:24 pm Purchase | 2025-09-30 | 13G | SAB Biotherapeutics, Inc. SABS | BIOTECHNOLOGY VALUE FUND L P | 5,167,618 9.990% | 5,167,618 (New Position) | Filing History |
| 2025-11-14 4:21 pm Sale | 2025-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -1,470,500 (Position Closed) | Filing History |
| 2025-11-14 4:19 pm Purchase | 2025-09-30 | 13G | Palvella Therapeutics, Inc. PVLA | BIOTECHNOLOGY VALUE FUND L P | 1,181,194 9.990% | 13,077 (+1.12%) | Filing History |
| 2025-11-14 4:17 pm Sale | 2025-09-30 | 13G | Protagonist Therapeutics, Inc. PTGX | BIOTECHNOLOGY VALUE FUND L P | 2,560,916 4.100% | -650,125 (-20.25%) | Filing History |
| 2025-11-14 4:14 pm Sale | 2025-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM | BIOTECHNOLOGY VALUE FUND L P | 1,495,290 3.000% | -1,580,617 (-51.39%) | Filing History |
| 2025-11-14 4:12 pm Purchase | 2025-09-30 | 13G | Kura Oncology, Inc. KURA | BIOTECHNOLOGY VALUE FUND L P | 8,677,018 9.990% | 2,764,464 (+46.76%) | Filing History |
| 2025-11-14 4:09 pm Purchase | 2025-09-30 | 13G | ImageneBio Inc IMA | BIOTECHNOLOGY VALUE FUND L P | 802,102 7.200% | 802,102 (New Position) | Filing History |
| 2025-11-14 4:08 pm Sale | 2025-09-30 | 13G | Forte Biosciences, Inc. FBRX | BIOTECHNOLOGY VALUE FUND L P | 65,350 0.500% | -578,272 (-89.85%) | Filing History |
| 2025-11-14 4:06 pm Sale | 2025-09-30 | 13G | Celcuity Inc. CELC | BIOTECHNOLOGY VALUE FUND L P | 658,421 1.600% | -2,807,579 (-81.00%) | Filing History |
| 2025-11-14 4:00 pm Purchase | 2025-09-30 | 13G | Avalo Therapeutics, Inc. AVTX | BIOTECHNOLOGY VALUE FUND L P | 1,458,151 9.990% | 419,609 (+40.40%) | Filing History |
| 2025-11-10 5:27 pm Unchanged | 2025-11-06 | 13D | MoonLake Immunotherapeutics MLTX | BIOTECHNOLOGY VALUE FUND L P | 19,751,284 27.700% | 0 (Unchanged) | Filing History |
| 2025-11-04 6:57 pm Purchase | 2025-10-31 | 13G | NEWCELX LTD SHS NCEL | BIOTECHNOLOGY VALUE FUND L P | 28,732 0.600% | 28,732 (New Position) | Filing History |
| 2025-10-29 5:24 pm Purchase | 2025-10-22 | 13G | Compass Therapeutics, Inc. CMPX | BIOTECHNOLOGY VALUE FUND L P | 8,750,000 5.100% | 8,750,000 (New Position) | Filing History |
| 2025-10-22 8:00 pm Purchase | 2025-10-15 | 13G | Invivyd, Inc. IVVD | BIOTECHNOLOGY VALUE FUND L P | 16,000,000 7.400% | 16,000,000 (New Position) | Filing History |
| 2025-10-17 4:56 pm Purchase | 2025-10-09 | 13G | Xencor, Inc. XNCR | BIOTECHNOLOGY VALUE FUND L P | 4,619,341 6.500% | 4,619,341 (New Position) | Filing History |
| 2025-10-17 4:48 pm Sale | 2025-10-15 | 13G | Cidara Therapeutics, Inc. CDTX | BIOTECHNOLOGY VALUE FUND L P | 1,189,165 4.400% | -225,000 (-15.91%) | Filing History |